Literature DB >> 7899228

Insulin fragments as a carrier for peptide delivery across the blood-brain barrier.

M Fukuta1, H Okada, S Iinuma, S Yanai, H Toguchi.   

Abstract

The possibility of using insulin (INS), which is transported into the brain by receptor-mediated transcytosis, as a peptide carrier for delivery across the blood-brain barrier (BBB) was investigated. After mice received an i.v. injection of horseradish peroxidase (HRP, M.W., 40,000) conjugated with INS, the HRP activity in the brain was higher than that after HRP injection. Since INS-HRP lowered the blood glucose level, we prepared insulin fragments by chemical and enzymatic procedures in an effort to find a carrier with no hypoglycemic activity. Seven fragments were synthesized taking the binding regions into consideration, but none showed any receptor binding affinity in cultures of bovine brain microvessel endothelial cells (BMEC). However, the fragment (F007) obtained by trypsin digestion showed high affinity and scarcely any hypoglycemic activity in mice even at a dose ten times the effective dose of insulin. These results suggest that this fragment may be useful as a carrier to transport therapeutic peptides across the BBB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899228     DOI: 10.1023/a:1018942728317

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.

Authors:  P M Friden; L R Walus; G F Musso; M A Taylor; B Malfroy; R M Starzyk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 2.  The use of cultured epithelial and endothelial cells for drug transport and metabolism studies.

Authors:  K L Audus; R L Bartel; I J Hidalgo; R T Borchardt
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

3.  Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

Authors:  U Bickel; T Yoshikawa; E M Landaw; K F Faull; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels.

Authors:  H J Frank; W M Pardridge; W L Morris; R G Rosenfeld; T B Choi
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

5.  A new case of abnormal insulinemia with diabetes. Reduced insulin values determined by radioreceptor assay.

Authors:  Y Iwamoto; H Sakura; Y Ishii; R Yamamoto; S Kumakura; Y Sakamoto; A Matsuda; T Kuzuya
Journal:  Diabetes       Date:  1986-11       Impact factor: 9.461

6.  NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants.

Authors:  A C Granholm; C Bäckman; F Bloom; T Ebendal; G A Gerhardt; B Hoffer; L Mackerlova; L Olson; S Söderström; L R Walus
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

7.  Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.

Authors:  K Nanjo; T Sanke; M Miyano; K Okai; R Sowa; M Kondo; S Nishimura; K Iwo; K Miyamura; B D Given
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  Permeability and mechanism of albumin, cationized albumin, and glycosylated albumin transcellular transport across monolayers of cultured bovine brain capillary endothelial cells.

Authors:  K R Smith; R T Borchardt
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

9.  Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin.

Authors:  M Haneda; S J Chan; S C Kwok; A H Rubenstein; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Receptor-mediated endocytosis of transferrin at the blood-brain barrier.

Authors:  R L Roberts; R E Fine; A Sandra
Journal:  J Cell Sci       Date:  1993-02       Impact factor: 5.285

View more
  5 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

2.  Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro.

Authors:  Julia V Georgieva; Dharamdajal Kalicharan; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Dick Hoekstra; Inge S Zuhorn
Journal:  Mol Ther       Date:  2010-11-02       Impact factor: 11.454

3.  Recombinant human sulphamidase: expression, amplification, purification and characterization.

Authors:  J Bielicki; J J Hopwood; E L Melville; D S Anson
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Expression, purification and characterization of recombinant caprine N-acetylglucosamine-6-sulphatase.

Authors:  T Litjens; J Bielicki; D S Anson; K Friderici; M Z Jones; J J Hopwood
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

5.  Current Challenges and Opportunities in Treating Glioblastoma.

Authors:  Andrea Shergalis; Armand Bankhead; Urarika Luesakul; Nongnuj Muangsin; Nouri Neamati
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.